Fig. 8From: Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 dataThe predicted probabilities of experiencing a DLT and corresponding 95 % prediction intervals for the conservative prior skeleton approach in the extended CRM method after the MTD has been determined for the AZD3514 dataBack to article page